77 related articles for article (PubMed ID: 1492636)
1. Neo-adjuvant hormonotherapy does not facilitate radical prostatectomy.
Van Poppel H; Ameye F; Oyen R; Van De Voorde W; Baert L
Acta Urol Belg; 1992; 60(3):73-82. PubMed ID: 1492636
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant hormonotherapy in patients with clinically-localized prostate cancer treated by radical prostatectomy: pathological results.
Têtu B
Can J Oncol; 1994 Nov; 4 Suppl 1():33-4; discussion 35-6. PubMed ID: 8853487
[No Abstract] [Full Text] [Related]
3. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
Labrie F; Dupont A; Cusan L; Gomez J; Diamond P; Koutsilieris M; Suburu R; Fradet Y; Lemay M; Têtu B
Clin Invest Med; 1993 Dec; 16(6):499-509. PubMed ID: 8013155
[TBL] [Abstract][Full Text] [Related]
4. Pilot trial of adjuvant paclitaxel plus estramustine in resected high-risk prostate cancer.
Cetnar JP; Malkowicz SB; Palmer SC; Wein AJ; Vaughn DJ
Urology; 2008 May; 71(5):942-6. PubMed ID: 18279928
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant hormonal deprivation before radical prostatectomy.
Schulman CC; Sassine AM
Clin Invest Med; 1993 Dec; 16(6):523-31. PubMed ID: 7516836
[TBL] [Abstract][Full Text] [Related]
6. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
Zincke H; Lau W; Bergstralh E; Blute ML
J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
[TBL] [Abstract][Full Text] [Related]
7. [The role of neoadjuvant treatment prior to radical prostatectomy].
Sassine AM; Schulman C
Acta Urol Belg; 1992; 60(3):61-71. PubMed ID: 1492635
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
[TBL] [Abstract][Full Text] [Related]
9. [Hormone therapy before radical prostatectomy. Effects on surgical method and resection margins. Belgian Uro-Oncological Study Group (B.U.O.S.)].
De Ridder D; Elgamal A; Werbrouck P; Ackaert K; Van Poppel H; Van de Voorde W; Oyen R; Baert L
Acta Urol Belg; 1994 Apr; 62(1):61-5. PubMed ID: 8197931
[TBL] [Abstract][Full Text] [Related]
10. Estimation of total PSA with a supersensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostate.
Spitz J; Enzmann T; Müller W; Weidenfeld M; Köllermann M
Anticancer Res; 1999; 19(4A):2637-40. PubMed ID: 10470209
[TBL] [Abstract][Full Text] [Related]
11. Hormone ablation therapy as neoadjuvant treatment to radical prostatectomy.
Solomon MH; McHugh TA; Dorr RP; Lee F; Siders DB
Clin Invest Med; 1993 Dec; 16(6):532-8. PubMed ID: 8013157
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience.
Debruyne FM; Witjes WP
Mol Urol; 2000; 4(3):251-6;discussion 257. PubMed ID: 11062381
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer.
Wirth MP; Weissbach L; Marx FJ; Heckl W; Jellinghaus W; Riedmiller H; Noack B; Hinke A; Froehner M
Eur Urol; 2004 Mar; 45(3):267-70; discussion 270. PubMed ID: 15036669
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
Andros EA; Danesghari F; Crawford ED
Clin Invest Med; 1993 Dec; 16(6):510-5. PubMed ID: 7516835
[TBL] [Abstract][Full Text] [Related]
15. [Clinical impact of neoadjuvant treatment to radical prostatectomy in locally advanced prostatic cancer].
Villavicencio H; Laguna P; Ponce de Léon J
Actas Urol Esp; 1994 May; 18 Suppl():404-8. PubMed ID: 8073926
[TBL] [Abstract][Full Text] [Related]
16. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
[TBL] [Abstract][Full Text] [Related]
17. The impact of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy: a matched pair analysis.
Maldonado-Valadez R; Teber D; Erdogru T; Safi KC; Frede T; Rassweiler J
J Urol; 2006 Jun; 175(6):2092-6. PubMed ID: 16697810
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
Hermans BP; Lorge F; Wese FX; Opsomer RJ; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):27-31. PubMed ID: 8659332
[No Abstract] [Full Text] [Related]
19. Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer.
Fair WR; Aprikian AG; Cohen D; Sogani P; Reuter V
Clin Invest Med; 1993 Dec; 16(6):516-22. PubMed ID: 8013156
[TBL] [Abstract][Full Text] [Related]
20. [Radical prostatectomy after complete androgen blockade in stage B2 and C cancer].
Peyrottes A; Benizri E; Chevallier D; Volpe P; Michiels JF; Amiel J; Toubol J
J Urol (Paris); 1994; 100(6):290-3. PubMed ID: 7745257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]